(Q33357008)
Statements
1 reference
Phase I and pharmacokinetic study of triapine, a potent ribonucleotide reductase inhibitor, administered daily for five days in patients with advanced solid tumors (English)
1 reference
Mario Sznol
1 reference
John Murren
1 reference
Manuel Modiano
1 reference
Caroline Clairmont
1 reference
Paula Lambert
1 reference
Niramol Savaraj
1 reference
Terry Doyle
1 reference
1 September 2003
1 reference
15 September 2003
1 reference
11
1 reference
4092-4100
1 reference
Identifiers
1 reference